Clinical Trial Update: Valacyclovir for Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating valacyclovir for mild cognitive impairment in individuals with herpes simplex infections has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Herpes Simplex Virus Infection Type

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Mild Cognitive Impairment, Herpes Simplex 1 | Phase 2 | Status: COMPLETED | Results posted: 2026-03-31